Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Subcutaneous Implantable Defibrillator (S-ICD) System - CE Clinical Investigation

NCT: NCT01117792 · COMPLETED

NCT IDNCT01117792
StatusCOMPLETED
Start Date2008-12
Completion2009-08
SponsorBoston Scientific Corporation (INDUSTRY)
First posted
Last updated

Brief Summary

The primary objective is to evaluate the S-ICD system's ability to identify and terminate induced ventricular fibrillation in patients during the implant procedure. The safety and performance of the S-ICD system will also be assessed throughout the patient follow-up period.

Frequently Asked Questions

What is Subcutaneous Implantable Defibrillator (S-ICD) System - CE Clinical Investigation?

Subcutaneous Implantable Defibrillator (S-ICD) System - CE Clinical Investigation is a clinical trial registered under NCT01117792. Current status: COMPLETED.

What is the status of NCT01117792?

The current status of NCT01117792 (Subcutaneous Implantable Defibrillator (S-ICD) System - CE Clinical Investigation) is: COMPLETED.

When did Subcutaneous Implantable Defibrillator (S-ICD) System - CE Clinical Investigation start?

Subcutaneous Implantable Defibrillator (S-ICD) System - CE Clinical Investigation started on 2008-12.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑